CHU de Montpellier — Montpellier

Public research footprint of CHU de Montpellier, compiled from the ClinicalTrials.gov public registry.

493

Registered studies

195

Active

134

Recruiting now

208

Completed

Stopped or withdrawn

Most-studied conditions

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Chronic Lymphocytic Leukemia · Heart Failure With Reduced Ejection Fraction · Fascioscapulohumeral Muscular Dystrophy Type 1

Recently updated registry entries

NCT07585097 — A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome… (Recruiting)
NCT06880744 — A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… (Active Not Recruiting)
NCT07332091 — Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Montpellier?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.